Recently updated National Comprehensive Cancer Network (NCCN) guidelines recommend testing for alterations in KRAS, NRAS, and BRAF as part of the initial workup for metastatic colorectal cancer (CRC; NCCN, 2015). The gene discussed is KRAS; the disease is colorectal carcinoma.